288 related articles for article (PubMed ID: 26895108)
1. HMGA1-pseudogenes and cancer.
De Martino M; Forzati F; Arra C; Fusco A; Esposito F
Oncotarget; 2016 May; 7(19):28724-35. PubMed ID: 26895108
[TBL] [Abstract][Full Text] [Related]
2. Dual role for SUMO E2 conjugase Ubc9 in modulating the transforming and growth-promoting properties of the HMGA1b architectural transcription factor.
Li Y; Lu J; Prochownik EV
J Biol Chem; 2007 May; 282(18):13363-71. PubMed ID: 17350957
[TBL] [Abstract][Full Text] [Related]
3. Interaction of adriamycin with a promoter region of hmga1 and its inhibitory effect on HMGA1 expression in A431 human squamous carcinoma cell line.
Akhter MZ; Sharma A; Rajeswari MR
Mol Biosyst; 2011 Apr; 7(4):1336-46. PubMed ID: 21336378
[TBL] [Abstract][Full Text] [Related]
4. Two new miR-16 targets: caprin-1 and HMGA1, proteins implicated in cell proliferation.
Kaddar T; Rouault JP; Chien WW; Chebel A; Gadoux M; Salles G; Ffrench M; Magaud JP
Biol Cell; 2009 Sep; 101(9):511-24. PubMed ID: 19250063
[TBL] [Abstract][Full Text] [Related]
5. Characterization of
De Martino M; Palma G; Arra C; Chieffi P; Fusco A; Esposito F
Cell Cycle; 2020 Sep; 19(18):2281-2285. PubMed ID: 32787507
[TBL] [Abstract][Full Text] [Related]
6. MYC-regulated pseudogene HMGA1P6 promotes ovarian cancer malignancy via augmenting the oncogenic HMGA1/2.
Tian X; Song J; Zhang X; Yan M; Wang S; Wang Y; Xu L; Zhao L; Wei JJ; Shao C; Kong B; Liu Z
Cell Death Dis; 2020 Mar; 11(3):167. PubMed ID: 32127525
[TBL] [Abstract][Full Text] [Related]
7. A mass spectrometric study on the in vitro methylation of HMGA1a and HMGA1b proteins by PRMTs: methylation specificity, the effect of binding to AT-rich duplex DNA, and the effect of C-terminal phosphorylation.
Zou Y; Webb K; Perna AD; Zhang Q; Clarke S; Wang Y
Biochemistry; 2007 Jul; 46(26):7896-906. PubMed ID: 17550233
[TBL] [Abstract][Full Text] [Related]
8. HMGA1 and HMGA2 expression and comparative analyses of HMGA2, Lin28 and let-7 miRNAs in oral squamous cell carcinoma.
Sterenczak KA; Eckardt A; Kampmann A; Willenbrock S; Eberle N; Länger F; Kleinschmidt S; Hewicker-Trautwein M; Kreipe H; Nolte I; Murua Escobar H; Gellrich NC
BMC Cancer; 2014 Sep; 14():694. PubMed ID: 25245141
[TBL] [Abstract][Full Text] [Related]
9. Dynamic and differential in vivo modifications of the isoform HMGA1a and HMGA1b chromatin proteins.
Edberg DD; Adkins JN; Springer DL; Reeves R
J Biol Chem; 2005 Mar; 280(10):8961-73. PubMed ID: 15591590
[TBL] [Abstract][Full Text] [Related]
10. Functional roles of pseudogenes in cancers.
Tang JS; Yang MY; Li Y
Yi Chuan; 2015 Jan; 37(1):8-16. PubMed ID: 25608808
[TBL] [Abstract][Full Text] [Related]
11. The canine HMGA1.
Murua Escobar H; Soller JT; Richter A; Meyer B; Winkler S; Flohr AM; Nolte I; Bullerdiek J
Gene; 2004 Apr; 330():93-9. PubMed ID: 15087128
[TBL] [Abstract][Full Text] [Related]
12. Regulation of microRNA expression by HMGA1 proteins.
De Martino I; Visone R; Fedele M; Petrocca F; Palmieri D; Martinez Hoyos J; Forzati F; Croce CM; Fusco A
Oncogene; 2009 Mar; 28(11):1432-42. PubMed ID: 19169275
[TBL] [Abstract][Full Text] [Related]
13. The HMGA proteins: a myriad of functions (Review).
Cleynen I; Van de Ven WJ
Int J Oncol; 2008 Feb; 32(2):289-305. PubMed ID: 18202751
[TBL] [Abstract][Full Text] [Related]
14. Homeodomain-interacting protein kinase-2 (HIPK2) phosphorylates HMGA1a at Ser-35, Thr-52, and Thr-77 and modulates its DNA binding affinity.
Zhang Q; Wang Y
J Proteome Res; 2007 Dec; 6(12):4711-9. PubMed ID: 17960875
[TBL] [Abstract][Full Text] [Related]
15. HMGA1-pseudogene7 transgenic mice develop B cell lymphomas.
De Martino M; De Biase D; Forzati F; Credendino SC; Palma G; Barbieri A; Arra C; Paciello O; Gaudio E; Ponzoni M; De Vita G; Chieffi P; Bertoni F; Fusco A; Esposito F
Sci Rep; 2020 Apr; 10(1):7057. PubMed ID: 32341372
[TBL] [Abstract][Full Text] [Related]
16. HMGA1-pseudogene overexpression contributes to cancer progression.
Esposito F; De Martino M; Forzati F; Fusco A
Cell Cycle; 2014; 13(23):3636-9. PubMed ID: 25483074
[TBL] [Abstract][Full Text] [Related]
17. The high mobility group A1 molecular switch: turning on cancer - can we turn it off?
Huso TH; Resar LM
Expert Opin Ther Targets; 2014 May; 18(5):541-53. PubMed ID: 24684280
[TBL] [Abstract][Full Text] [Related]
18. Tandem mass spectrometry for the examination of the posttranslational modifications of high-mobility group A1 proteins: symmetric and asymmetric dimethylation of Arg25 in HMGA1a protein.
Zou Y; Wang Y
Biochemistry; 2005 Apr; 44(16):6293-301. PubMed ID: 15835918
[TBL] [Abstract][Full Text] [Related]
19. Expression of high mobility group A proteins in oral leukoplakia.
Larsson L; Jäwert F; Magnusson B; Hasséus B; Kjeller G
Anticancer Res; 2013 Oct; 33(10):4261-6. PubMed ID: 24122990
[TBL] [Abstract][Full Text] [Related]
20. Mass spectrometric analysis of high-mobility group proteins and their post-translational modifications in normal and cancerous human breast tissues.
Zou Y; Wang Y
J Proteome Res; 2007 Jun; 6(6):2304-14. PubMed ID: 17455969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
